An 8-year retrospective review of gastrointestinal medical emergency conditions at a tertiary health facility in Nigeria

Oguntoye  Oluwatosin Oluwagbenga; Yusuf  Musah

doi:10.52981/sjms.v13i1.1057

Oguntoye Oluwatosin Oluwagbenga Afe Babalola University
Yusuf Musah Babalola University

DOI: https://doi.org/10.52981/sjms.v13i1.1057

Keywords: gastrointestinal, medical, emergency room

Abstract

Background: Globally, gastrointestinal emergency conditions constitute a considerable proportion of the medical emergency cases seen in the emergency room.

Objective: This study investigated the spectrum of gastrointestinal medical emergency conditions seen in the emergency room of Federal Teaching Hospital Ido-Ekiti, Nigeria.

Materials and Methods: The emergency room admission register was used to obtain the following information: Age, Sex, Diagnosis, Year of admission and the Outcome. The period under review was 1st January 2009 to 31st December 2016. The data was analyzed using the SPSS version 21.0 software package.

Results: A total number of 5,912 patients with medical emergency conditions were admitted into the emergency room during the period under review, out of which 813(13.7%) were gastrointestinal medical emergency conditions. The age range of the patients was 15 to 100years with a mean(±SD) of 47.32±18.938. Acute exacerbation of acid peptic disorders(29.3%) was the most common indication for emergency room admission followed by acute gastroenteritis(26.8%) and decompensated chronic liver disease(14.3%). Decompensated chronic liver disease and upper gastrointestinal bleeding were the conditions with the highest mortality being 31.8% and 29.5% respectively.

Conclusion: Gastrointestinal medical conditions are common indications for emergency admission. Measures should be taken to avoid these preventable conditions in a bid to reduce their morbidity and mortality.

References

[1] Ogah OS, Akinyemi RO, Adesemowo A and Ogbodo EI. A Two-Year Review ofMedical Admissions at the Emergency Unit of a Nigerian Tertiary HealthFacility.Afr. J. Biomed. Res. 2012; 15: 59 – 63.
[2] Odenigbo CU and Oguejiofor OC. Pattern of medical admissions at the FederalMedical Centre, Asaba - a two year review. Niger J Clin Pract. 2009; 12: 395-397.
[3] Ogun SA, Adelowo OO, Familoni OB, Jaiyesimi AE and Fakoya EA. Pattern andoutcome of medical admissions at the Ogun State University Teaching Hospital,Sagamu - a three year review. West Afr J Med. 2000; 19: 304-308.
[4] Lewis J, Bilker W and Brensinger C. Hospitalization and mortality rates from pepticulcer disease and GI bleeding in the 1990s: Relationship to sales of Nonsteroidalanti-inflammatory drugs and acid suppression medications. Am J Gastroenterol.2002; 97: 2540-2549.
[5] Rockhall TA, Logan RF, Devlin HB and Northfield TC. Incidence of and mortalityfrom acute upper gastrointestinal haemorrhage in the United Kingdom. SteeringCommittee and members of the National Audit of Acute Upper GastrointestinalHaemorrhage. BMJ. 1995; 311:222-226.
[6] Bloom S, Webster G and Marks D ed. Emergencies. In Oxford Handbook ofGastroenterology and Hepatology. 2nd edition. Oxford Univeristy Press 2012;Section 5: 563-597.
[7] Hameed L, Onyekwere AC, Otegbayo JA and Abdulkareem FB. A clinicopathologicalstudy of dyspeptic subjects in Lagos, Nigeria. Gastroenterol Insights 2012;4:e11.
[8] Jemilohun AC, Otegbayo JA, Ola SO, Oluwasola OA and Akere A. Prevalence ofhelicobacter pylori among Nigerian patients with dyspepsia in Ibadan. Pan AfricanMedical Journal 2011; 6:18-25.
[9] Nwokediuku S, Omuemu C and Akere A. Guidelines for the management of dyspepsiaand gastroesophageal reflux disease. Nigerian Journal of Gastroenterologyand Hepatology 2015; 7(2):93-108.
[10] Malu AO, Borodo MM, Ndububa DA, Ojo OS, Anomneze EE, Lesi OA et al. HepatitisB and C treatment guidelines for Nigeria 2015. Nigerian Journal of Gastroenterologyand Hepatology 2015;7(2):63-75.
[11] Musa BM, Bussell S, Borodo MM, Samaila AA and Femi OL. Prevalence of Hepatitis Bvirus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. NigerJ Clin Pract. 2015;18:163-172.
[12] Ndububa D, Ojo O, Lesi O, Samaila A and Ngim O. Management of HepatocellularCarcinoma. Nigerian Journal of Gastroenterology and Hepatology 2015;7(2):77-92.
[13] Rukewe A, Otegbayo JA and Fatiregun A. Clinical characteristics and outcome ofpatients with upper gastrointestinal bleeding at the emergency department of atertiary hospital in Nigeria. Annals of Ibadan Postgraduate Medicine2015;13(2):24-28.
[14] Ajayi AO, Adegun PT, Ajayi EA, Solomon OA, Adeoti AO and Akolawole MA.Aetiology and Management Outcome of Upper Gastrointestinal Bleeding in AdultPatients Presenting at Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.Greener Journal of Medical Sciences 2013; 3(3):93-97.
[15] Mellemkjaer L, Blot WJ and Sørensen HT. Upper gastrointestinal bleeding amongusers of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol.2002; 53:173-181.
[16] Holster IL and Kuipers EJ. Management of acute nonvariceal upper gastrointestinalbleeding: current policies. World J Gastroenterol. 2012;18(11): 1202-1207.